ClinConnect ClinConnect Logo
Search / Trial NCT06318195

Condensed Digital Prolonged Exposure for Individuals Treated Within Somatic Trauma Care.

Launched by KAROLINSKA INSTITUTET · Mar 12, 2024

Trial Information

Current as of August 22, 2025

Not yet recruiting

Keywords

Condensed Prolonged Exposure Internet Delivered Ptsd Trauma Early Intervention Prevention Cipe

ClinConnect Summary

This clinical trial is looking at a new online treatment for people who have experienced trauma and are showing signs of Post-Traumatic Stress Disorder (PTSD) or Acute Stress Disorder (ASD). The goal is to see if this short, internet-based therapy, which focuses on trauma, can help those who have recently received care for their trauma at Karolinska University Hospital. Researchers want to learn how well the treatment works and what factors might affect its success for different individuals.

To join the study, participants need to be at least 18 years old and have experienced a traumatic event in the last two months, such as a serious injury or violence. They will also need to show some symptoms of PTSD. However, people with certain serious mental health conditions, those who cannot read or write in Swedish, or those receiving other trauma-focused treatments won't be able to participate. Once enrolled, participants can expect to engage in an online therapy program designed to help them cope with their experiences. This trial is currently not recruiting participants, but it aims to gather valuable information to improve care for those affected by trauma in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Exposed to trauma in the past two months according to criterion A for PTSD in the DSM-5 (exposed to death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence).
  • PCL-5 total sum score\>10
  • ≥ 18 years
  • Situated in Sweden
  • Signed informed consent
  • Exclusion Criteria:
  • Other serious comorbidity as primary concern (ongoing substance dependence, untreated bipolar disorder, psychotic symptoms, severe depression, borderline personality disorder, high suicidal risk according to the MINI)
  • Unable to read and write in Swedish
  • Receiving other psychological trauma-focused treatment
  • Ongoing trauma-related threat (e.g., living with a violent spouse)
  • Not stable dose of antidepressant medication the last two weeks

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Maria Bragesjö, PhD

Principal Investigator

Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported